Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue

The Keap1-Nrf2 signaling axis is a validated and promising target for cellular defense and survival pathways. This minireview discusses the potential off-target effects and their impact on future drug development originating from Keap1-targeting small molecules that function as displacement activato...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Aging Neurosci
Päätekijät: Hushpulian, Dmitry M., Ammal Kaidery, Navneet, Ahuja, Manuj, Poloznikov, Andrey A., Sharma, Sudarshana M., Gazaryan, Irina G., Thomas, Bobby
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Neuroscience
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8060438/
https://ncbi.nlm.nih.gov/pubmed/33897412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2021.673205
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia